1. LBA-001Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial. (2nd July 2019) Authors: Golan, T; Hammel, P; Reni, M; Van Cutsem, E; Macarulla, T; Hall, M; Park, J; Hochhauser, D; Arnold, D; Oh, D; Reinacher-Schick, A; Tortora, G; Algül, H; O'Reilly, E; McGuinness, D; Cui, K; Schlienger, K; Locker, G; Kindler, H Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 83POlaparib plus paclitaxel sensitivity in biomarker subgroups of gastric cancer. (23rd October 2018) Authors: Liu, Y-Z; Hodgson, D; Locker, G; Lai, Z; Balcerzak, D; Sharpe, A; Barrett, J C; Orr, M; Gutjahr, T S; Dougherty, B; Roudier, M P; Shi, X; Miller, R; Kim, W H; Zeng, X; Ochiai, A; Im, S-A; Xu, R-H; Boku, N; Bang, Y-J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Frequency of glove puncture in the post mortem room. Issue 2 (February 1992) Authors: Weston, J; Locker, G Journal: Journal of clinical pathology Issue: Volume 45:Issue 2(1992) Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗